Todisco Joseph — SEC insider filings

SEC reporting owner CIK 1774807. 32 insider filings on record with FilingPulse; latest filed 2026-11-16.

Transaction summary — filings shown

Covers all 32 filings on record, filed 2021-03-02 to 2026-11-16. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
CorMedix Inc. (CRMD)Chief Executive Officer, Director227 legs · 143,261 sh · $630,5422 legs · 80,000 sh · $1,010,00026
Amneal Pharmaceuticals, Inc. (AMRX)Executive Vice President8—2 legs · 37,830 sh · $254,01527
TALPHERA, INC. (TLPH)Director2——4

Insider filings — Todisco Joseph

FiledFormIssuerReported transactionsSource
2026-11-164CorMedix Inc. (CRMD)Purchase (P): 80,000 @ $4.89EDGAR
2026-06-244TALPHERA, INC. (TLPH)Grant/award (A): 5,100 @ $0 · Grant/award (A): 30,700 (derivative) @ $0EDGAR
2026-02-064CorMedix Inc. (CRMD)Grant/award (A): 77,156 @ $0EDGAR
2026-01-274CorMedix Inc. (CRMD)Grant/award (A): 225,900 @ $0 · Tax withholding (F): 27,306 @ $7.27EDGAR
2026-01-204CorMedix Inc. (CRMD)Tax withholding (F): 17,417 @ $7.15 · Option exercise (M): 29,585 @ $3.38 · Tax withholding (F): 22,665 @ $6.78 · Option exercise (M): 29,585 (derivative) @ $0EDGAR
2025-12-194CorMedix Inc. (CRMD)Option exercise (M): 30,000 @ $4.43 · Sale (S): 30,000 @ $12 · Option exercise (M): 30,000 (derivative) @ $0EDGAR
2025-10-164TALPHERA, INC. (TLPH)Grant/award (A): 6,397 @ $0 · Grant/award (A): 38,381 (derivative) @ $0EDGAR
2025-09-124CorMedix Inc. (CRMD)Tax withholding (F): 21,225 @ $11.66EDGAR
2025-09-124CorMedix Inc. (CRMD)Option exercise (M): 50,000 @ $3.47 · Sale (S): 50,000 @ $13 · Option exercise (M): 50,000 (derivative) @ $0EDGAR
2025-04-024CorMedix Inc. (CRMD)Option exercise (M): 59,170 @ $3.38 · Option exercise (M): 59,170 (derivative) @ $0EDGAR
2025-01-224CorMedix Inc. (CRMD)Grant/award (A): 187,500 @ $0 · Tax withholding (F): 23,977 @ $12.17EDGAR
2025-01-144CorMedix Inc. (CRMD)Tax withholding (F): 17,829 @ $11.19EDGAR
2024-05-134CorMedix Inc. (CRMD)Tax withholding (F): 26,982 @ $5.17EDGAR
2024-03-144CorMedix Inc. (CRMD)Purchase (P): 13,561 @ $3.74EDGAR
2024-01-174CorMedix Inc. (CRMD)Grant/award (A): 133,333 @ $0 · Tax withholding (F): 13,781 @ $3.47 · Grant/award (A): 266,667 (derivative) @ $0EDGAR
2023-09-084CorMedix Inc. (CRMD)Purchase (P): 10,000 @ $3.71EDGAR
2023-05-184/ACorMedix Inc. (CRMD)Purchase (P): 5,000 @ $4.58EDGAR
2023-05-174CorMedix Inc. (CRMD)Grant/award (A): 5,000 @ $4.58EDGAR
2023-05-124CorMedix Inc. (CRMD)Tax withholding (F): 37,443 @ $5.30EDGAR
2023-01-184CorMedix Inc. (CRMD)Grant/award (A): 400,000 (derivative) @ $0EDGAR
2022-11-164CorMedix Inc. (CRMD)Purchase (P): 20,000 @ $3.82EDGAR
2022-08-254CorMedix Inc. (CRMD)Purchase (P): 4,700 @ $3.92EDGAR
2022-05-174CorMedix Inc. (CRMD)Purchase (P): 10,000 @ $3.38EDGAR
2022-05-124CorMedix Inc. (CRMD)Grant/award (A): 207,469 @ $0 · Grant/award (A): 500,000 (derivative) @ $0EDGAR
2022-05-104Amneal Pharmaceuticals, Inc. (AMRX)Option exercise (M): 4,442 · Tax withholding (F): 1,562 @ $3.40 · Option exercise (M): 4,442 (derivative) @ $0EDGAR
2022-03-034Amneal Pharmaceuticals, Inc. (AMRX)Option exercise (M): 11,111 · Tax withholding (F): 3,906 @ $4.45 · Option exercise (M): 26,544 · Tax withholding (F): 9,331 @ $4.45 · Option exercise (M): 11,111 (derivative) @ $0 · Option exercise (M): 26,544 (derivative) @ $0 · +2 moreEDGAR
2022-03-014Amneal Pharmaceuticals, Inc. (AMRX)Option exercise (M): 29,684 · Tax withholding (F): 11,107 @ $4.59 · Option exercise (M): 29,684 (derivative) @ $0EDGAR
2021-12-034Amneal Pharmaceuticals, Inc. (AMRX)Sale (S): 1,500 @ $4.10EDGAR
2021-05-114Amneal Pharmaceuticals, Inc. (AMRX)Option exercise (M): 4,441 · Tax withholding (F): 1,562 @ $5.20 · Option exercise (M): 4,441 (derivative) @ $0EDGAR
2021-03-174Amneal Pharmaceuticals, Inc. (AMRX)Option exercise (M): 36,330 @ $2.75 · Sale (S): 36,330 @ $6.82 · Option exercise (M): 36,330 (derivative) @ $0EDGAR
2021-03-034Amneal Pharmaceuticals, Inc. (AMRX)Grant/award (A): 106,178 (derivative) @ $0 · Grant/award (A): 212,356 (derivative) @ $0EDGAR
2021-03-024Amneal Pharmaceuticals, Inc. (AMRX)Option exercise (M): 29,683 · Tax withholding (F): 10,972 @ $5.39 · Option exercise (M): 11,111 · Tax withholding (F): 3,906 @ $5.18 · Option exercise (M): 29,683 (derivative) @ $0 · Option exercise (M): 11,111 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2020-10-05 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1774807 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs